Home/Smart Money/Stonepine Capital Management, LLC
§ 13F · FUND PROFILE

Stonepine Capital Management, LLC.

AUM · $391M (13F)Positions · 184Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$55M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 14, 2026
#TickerNameShares$ value% portΔ Q2
1VSTMVERASTEM INC3.35M$13M3.3%—
2VSTMVERASTEM INC3.35M$13M3.3%+103%
3EOLSEVOLUS INC1.59M$11M2.8%—
4EOLSEVOLUS INC1.59M$11M2.8%+85%
5AYTUAYTU BIOPHARMA INC4.99M$10M2.5%+645%
6TENXTENAX THERAPEUTICS INC660K$10M2.5%—
7TENXTENAX THERAPEUTICS INC660K$10M2.5%+35%
8NKTRNEKTAR THERAPEUTICS121K$8M2.2%—
9NKTRNEKTAR THERAPEUTICS121K$8M2.2%+184%
10AZTRAZITRA INC81.80M$8M2.0%NEW
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE STONEPINE SIGNAL

AC read

Stonepine Capital Management, LLC is a Other fund managing $391 million in assets. The fund runs a portfolio of 184 positions.

Read the full dossier →